US FDA approves J&J's ketamine-based therapy to treat depression
ReutersJan 21, 2025 1:04 PM
Jan 21 (Reuters) - The U.S. Food and Drug Administration approved Johnson & Johnson's JNJ.N ketamine-based nasal spray Spravato, to treat adults with major depressive disorder, the company said on Tuesday.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Anil D'Silva)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.TradingKey
41 minutes ago
[Crypto IPO] OKX Burns Over 65 Million Tokens — OKB Skyrockets 200%
Cryptocurrency exchange OKX is reportedly preparing for a U.S. initial public offering, sending its native token OKB surging over 14%.TradingKey
an hour ago
China July Money Supply Preview: M2 Growth Expected to Remain Elevated
TradingKey - On 15 August 2025, the People's Bank of China will release the July data on broad money supply (M2). The market generally expects that the year-on-year growth rate of M2 in that month will be 8.2%. Although the projected year-on-year growth rate of M2 in July is expected to decrease byTradingKey
2 hours ago
Eurozone Q2 GDP Preview: Euro Losing Momentum, Likely to Enter a Fluctuation Range
TradingKey - On 14 August 2025, the eurozone will release its Q2 GDP data. Market consensus expects that the quarterly growth rate will slow to 0.1% in Q2, down from 0.6% in Q1, which will cause the year-on-year figure to drop by 0.1 percentage points compared to the previous reading.TradingKey
20 hours ago
Investing in Healthcare Stocks
TradingKey - After a year of underperformance, the health care sector is emerging as one of the most interesting places for long-term investors looking for a mixture of resilience and innovation. The health care stocks trailed broader indexes in 2024 as money poured into AI, technology...TradingKey
Tue, Aug 12
